FullHope Biomedical Co.,Ltd. (TPEX:7773)
Taiwan · Delayed Price · Currency is TWD 30.90
-0.15 (-0.48%)
At close: May 29, 2026
FullHope Biomedical Market Cap
FullHope Biomedical has a market cap or net worth of 1.23 billion as of May 29, 2026. Its market cap has decreased by -18.73% in one year.
Market Cap
1.23B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.90
Market Cap Chart
Since September 26, 2024, FullHope Biomedical's market cap has decreased from 2.19B to 1.23B, a decrease of -43.90%. That is a compound annual growth rate of -29.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.23B | 0.49% |
| Dec 31, 2025 | 1.22B | -21.71% |
| Dec 31, 2024 | 1.56B | -28.69% |
| Sep 26, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.98B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.17B |
| Uwell Biopharma | 8.03B |
| Intelligene | 6.67B |
| Obigen Pharma | 3.93B |
| Pet Pharm Biotech | 3.07B |
| BIONET Therapeutics | 2.62B |
| Genomics BioSci & Tech. | 1.22B |